Under FDA guidelines, pharmacies are not allowed to regularly compound medications that are exact copies of FDA-approved drugs, so they use additional ingredients, such as vitamins B6 and B12, L-carnitine, and nicotinamide adenine dinucleotide (NAD) to alter the recipe. Its unclear if combining these and other ingredients with GLP-1 drugs is safe or effective
The regulatory pathway for generic small molecules is well-established, straightforward, and relatively inexpensive compared to the biosimilar approval pathway for biologic peptides
If these results hold up, treatments like this could reshape the future burden of type 2 diabetes, heart disease, fatty liver, blood pressure strain, and long-term metabolic risk
doi:10.1002/jms.4996 What is CJC-1295 No DAC (10mg)
BPC 157 and NO system interaction